BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34684572)

  • 1. Vitamin D as Modulator of Drug Concentrations: A Study on Two Italian Cohorts of People Living with HIV Administered with Efavirenz.
    Cusato J; Tempestilli M; Calcagno A; Vergori A; Piselli P; Antonucci M; Avataneo V; Palermiti A; Notari S; Antinori A; Di Perri G; Agrati C; D'Avolio A
    Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between social psychological status and efavirenz and nevirapine plasma concentration among HIV patients in Kenya.
    Ngayo MO; Oluka M; Bulimo WD; Okalebo FA
    Sci Rep; 2021 Nov; 11(1):22071. PubMed ID: 34764325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Efavirenz Mid-dose Plasma Concentration on Long-Term Weight Change Among Virologically Suppressed People Living With HIV.
    Huang SH; Huang WC; Lin SW; Chuang YC; Sun HY; Chang SY; Kuo PH; Wu PY; Liu WC; Chiang C; Hung CC; Chang SC
    J Acquir Immune Defic Syndr; 2021 Jun; 87(2):834-841. PubMed ID: 33587507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and risk factors for efavirenz-based antiretroviral treatment-associated severe vitamin D deficiency: A prospective cohort study.
    Nylén H; Habtewold A; Makonnen E; Yimer G; Bertilsson L; Burhenne J; Diczfalusy U; Aklillu E
    Medicine (Baltimore); 2016 Aug; 95(34):e4631. PubMed ID: 27559961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cholecalciferol supplementation on serum and urinary vitamin D metabolites and binding protein in HIV-infected youth.
    Eckard AR; Thierry-Palmer M; Silvestrov N; Rosebush JC; O'Riordan MA; Daniels JE; Uribe-Leitz M; Labbato D; Ruff JH; Singh RJ; Tangpricha V; McComsey GA
    J Steroid Biochem Mol Biol; 2017 Apr; 168():38-48. PubMed ID: 28161530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between initiation of antiretroviral therapy with efavirenz and decreases in 25-hydroxyvitamin D.
    Brown TT; McComsey GA
    Antivir Ther; 2010; 15(3):425-9. PubMed ID: 20516561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Large variability in plasma efavirenz concentration in Papua New Guinea HIV/AIDS patients associated with high frequency of CYP2B6 516T allele.
    Bordin Andriguetti N; Van Schalkwyk HK; Barratt DT; Tucci J; Pumuye P; Somogyi AA
    Clin Transl Sci; 2021 Nov; 14(6):2521-2531. PubMed ID: 34415664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of vitamin D supplementation on the bone specific biomarkers in HIV infected individuals under treatment with efavirenz.
    Etminani-Esfahani M; Khalili H; Jafari S; Abdollahi A; Dashti-Khavidaki S
    BMC Res Notes; 2012 Apr; 5():204. PubMed ID: 22537736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals.
    Mbuagbaw L; Mursleen S; Irlam JH; Spaulding AB; Rutherford GW; Siegfried N
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD004246. PubMed ID: 27943261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher plasma drug levels in elderly people living with HIV treated with darunavir.
    Tyrberg E; Edén A; Eriksen J; Nilsson S; Treutiger CJ; Thalme A; Mellgren Å; Gisslén M; Andersson LM
    PLoS One; 2021; 16(2):e0246171. PubMed ID: 33539440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of association between plasma levels of non-nucleoside reverse transcriptase inhibitors & virological outcomes during rifampicin co-administration in HIV-infected TB patients.
    Ramachandran G; Kumar AK; Ponnuraja C; Ramesh K; Rajesh L; Chandrasekharan C; Swaminathan S
    Indian J Med Res; 2013 Dec; 138(6):955-61. PubMed ID: 24521642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High efavirenz levels but not neurofilament light plasma levels are associated with poor neurocognitive functioning in asymptomatic HIV patients.
    Hakkers CS; Hermans AM; van Maarseveen EM; Teunissen CE; Verberk IMW; Arends JE; Hoepelman AIM
    J Neurovirol; 2020 Aug; 26(4):572-580. PubMed ID: 32524424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compartmentalization and antiviral effect of efavirenz metabolites in blood plasma, seminal plasma, and cerebrospinal fluid.
    Avery LB; VanAusdall JL; Hendrix CW; Bumpus NN
    Drug Metab Dispos; 2013 Feb; 41(2):422-9. PubMed ID: 23166317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change in vitamin D levels and risk of severe vitamin D deficiency over 48 weeks among HIV-1-infected, treatment-naive adults receiving rilpivirine or efavirenz in a Phase III trial (ECHO).
    Wohl DA; Orkin C; Doroana M; Pilotto JH; Sungkanuparph S; Yeni P; Vanveggel S; Deckx H; Boven K
    Antivir Ther; 2014; 19(2):191-200. PubMed ID: 24430534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenetic-based efavirenz dose modification: suggestions for an African population and the different CYP2B6 genotypes.
    Mukonzo JK; Owen JS; Ogwal-Okeng J; Kuteesa RB; Nanzigu S; Sewankambo N; Thabane L; Gustafsson LL; Ross C; Aklillu E
    PLoS One; 2014; 9(1):e86919. PubMed ID: 24497997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma efavirenz concentrations and the association with CYP2B6-516G >T polymorphism in HIV-infected Thai children.
    Puthanakit T; Tanpaiboon P; Aurpibul L; Cressey TR; Sirisanthana V
    Antivir Ther; 2009; 14(3):315-20. PubMed ID: 19474465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efavirenz in the therapy of HIV infection.
    Rakhmanina NY; van den Anker JN
    Expert Opin Drug Metab Toxicol; 2010 Jan; 6(1):95-103. PubMed ID: 20001610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Association of Intraocular Efavirenz Concentrations and HIV-1 Viral Load Among Persons With HIV.
    Zhang P; Qian Y; Wang L; Suo J; Yin L; Wang Y; Zhang L; Wang Z
    J Acquir Immune Defic Syndr; 2024 Jul; 96(3):299-303. PubMed ID: 38534141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-free efavirenz concentrations in cerebrospinal fluid and blood plasma are equivalent: applying the law of mass action to predict protein-free drug concentration.
    Avery LB; Sacktor N; McArthur JC; Hendrix CW
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1409-14. PubMed ID: 23295919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of CYP2B6-516G > T Polymorphism with Plasma Efavirenz Concentration and Depression in HIV-Infected Adults in Northern Thailand.
    Aurpibul L; Chotirosniramit N; Sugandhavesa P; Kosashunhanan N; Thetket S; Supindham T; Piyamongkol W; Supparatpinyo K
    Curr HIV Res; 2012 Dec; 10(8):653-60. PubMed ID: 22950382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.